Skip to content
lifestyle.brightsfuture.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cantargia
Cantargia to host Q3 2026 Interim Results Conference Call
November 5, 2026
Cantargia Presents Promising Early Results with Nadunolimab in MDS and AML Ahead of ASH 2026
November 4, 2026
Cantargia Presents Nomination Committee Ahead of 2027 AGM
October 29, 2026
Cantargia to Present at the Stifel 2026 Healthcare Conference
October 27, 2026
Cantargia Appoints Dr. Monic Stuart as Chief Medical Officer
October 26, 2026
Cantargia Highlights Preclinical Data at AACR Supporting Nadunolimab in Combination with RAS Inhibition in PDAC
September 30, 2026
Cantargia to Participate in Upcoming Investor Conferences
August 28, 2026
Cantargia Publishes Half-Year Report 2026
August 19, 2026
Cantargia to Host Q2 2026 Interim Results Conference Call
August 4, 2026
Cantargia Announces Changes in Number of Shares and Votes
July 31, 2026
1
2
Next Page
→